Joe Ecker
627 posts






















Today, I am thrilled to introduce @PerturbAI_Tx, a company I co-founded to rethink drug discovery. Biology is complex, and disease unfolds across genes, cell types, and tissues. We’re powering AI with the causal logic of human genetics: perturb.ai

Introducing PerturbAI. Today we announced our emergence from stealth with the release of the world’s largest in vivo CRISPR data engine, interrogating the effects of thousands of genetic perturbations across 8 million cells throughout the whole brain. This dataset represents a new category of biological data: organism-level, circuit-resolved causal genomics leading to novel targets and therapeutics. By combining scalable in vivo CRISPR perturbation with AI, we model biological systems at unprecedented resolution and simulate therapeutic interventions before committing to expensive downstream development. We’re grateful to our collaborators at @NVIDIAHealth and @10xGenomics for helping make this landmark dataset possible. Read More: perturb.ai/news #CRISPR #AI #DrugDiscovery #FunctionalGenomics #Biotech





